Post operative patient recovery monitoring system based on biochemical readings that ensures patients are released at the right time, thereby freeing up bed occupancy and other resources.

Attomarker Ltd is a spin-out company from the University of Exeter, founded to develop a novel, label-free, array-based technology to monitor concentrations of large numbers of biomarkers in the blood to provide a differential diagnosis of disease to assist the clinical decision makers. Multiple simultaneous biomarker analysis of blood chemistry points to a new direction in diagnosis for complex conditions such as allergy or irritable bowel syndrome, or the recovery of patients from operations. The multi-marker analysis provides a view of the health of a patient, an allergy profile or a novel way to follow the recovery of a patient after a surgical procedure.